Literature DB >> 28151657

Evaluating the Contribution of Transition-State Destabilization to Changes in the Residence Time of Triazole-Based InhA Inhibitors.

Lauren A Spagnuolo1, Sandra Eltschkner2, Weixuan Yu1, Fereidoon Daryaee1, Shabnam Davoodi1, Susan E Knudson3, Eleanor K H Allen1, Jonathan Merino1, Annica Pschibul2, Ben Moree4, Neil Thivalapill5, James J Truglio5, Joshua Salafsky4, Richard A Slayden3, Caroline Kisker2, Peter J Tonge1.   

Abstract

A critical goal of lead compound selection and optimization is to maximize target engagement while minimizing off-target binding. Since target engagement is a function of both the thermodynamics and kinetics of drug-target interactions, it follows that the structures of both the ground states and transition states on the binding reaction coordinate are needed to rationally modulate the lifetime of the drug-target complex. Previously, we predicted the structure of the rate-limiting transition state that controlled the time-dependent inhibition of the enoyl-ACP reductase InhA. This led to the discovery of a triazole-containing diphenyl ether with an increased residence time on InhA due to transition-state destabilization rather than ground-state stabilization. In the present work, we evaluate the inhibition of InhA by 14 triazole-based diphenyl ethers and use a combination of enzyme kinetics and X-ray crystallography to generate a structure-kinetic relationship for time-dependent binding. We show that the triazole motif slows the rate of formation for the final drug-target complex by up to 3 orders of magnitude. In addition, we identify a novel inhibitor with a residence time on InhA of 220 min, which is 3.5-fold longer than that of the INH-NAD adduct formed by the tuberculosis drug, isoniazid. This study provides a clear example in which the lifetime of the drug-target complex is controlled by interactions in the transition state for inhibitor binding rather than the ground state of the enzyme-inhibitor complex, and demonstrates the important role that on-rates can play in drug-target residence time.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28151657      PMCID: PMC5357606          DOI: 10.1021/jacs.6b11148

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  40 in total

1.  Detection of protein conformational change by optical second-harmonic generation.

Authors:  Joshua S Salafsky
Journal:  J Chem Phys       Date:  2006-08-21       Impact factor: 3.488

2.  Mechanism of inhibition of fatty acid amide hydrolase by sulfonamide-containing benzothiazoles: long residence time derived from increased kinetic barrier and not exclusively from thermodynamic potency.

Authors:  Gaochao Tian; Kathy A Paschetto; Farzin Gharahdaghi; Euan Gordon; Dee E Wilkins; Xincai Luo; Clay W Scott
Journal:  Biochemistry       Date:  2011-07-22       Impact factor: 3.162

3.  Pharmacodynamics: Which trails are your drugs taking?

Authors:  Rumin Zhang
Journal:  Nat Chem Biol       Date:  2015-04-20       Impact factor: 15.040

4.  A [(32)P]NAD(+)-based method to identify and quantitate long residence time enoyl-acyl carrier protein reductase inhibitors.

Authors:  Weixuan Yu; Carla Neckles; Andrew Chang; Gopal Reddy Bommineni; Lauren Spagnuolo; Zhuo Zhang; Nina Liu; Christina Lai; James Truglio; Peter J Tonge
Journal:  Anal Biochem       Date:  2015-02-14       Impact factor: 3.365

5.  Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate.

Authors:  D A Rozwarski; C Vilchèze; M Sugantino; R Bittman; J C Sacchettini
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

6.  Novel inhibitors of InhA efficiently kill Mycobacterium tuberculosis under aerobic and anaerobic conditions.

Authors:  Catherine Vilchèze; Anthony D Baughn; JoAnn Tufariello; Lawrence W Leung; Mack Kuo; Christopher F Basler; David Alland; James C Sacchettini; Joel S Freundlich; William R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  2011-05-31       Impact factor: 5.191

7.  Design, synthesis, and evaluation of new thiadiazole-based direct inhibitors of enoyl acyl carrier protein reductase (InhA) for the treatment of tuberculosis.

Authors:  Roman Šink; Izidor Sosič; Matej Živec; Raquel Fernandez-Menendez; Samo Turk; Stane Pajk; Daniel Alvarez-Gomez; Eva Maria Lopez-Roman; Carolina Gonzales-Cortez; Joaquin Rullas-Triconado; Inigo Angulo-Barturen; David Barros; Lluís Ballell-Pages; Robert J Young; Lourdes Encinas; Stanislav Gobec
Journal:  J Med Chem       Date:  2014-12-29       Impact factor: 7.446

8.  Pyridomycin bridges the NADH- and substrate-binding pockets of the enoyl reductase InhA.

Authors:  Ruben C Hartkoorn; Florence Pojer; Jon A Read; Helen Gingell; João Neres; Oliver P Horlacher; Karl-Heinz Altmann; Stewart T Cole
Journal:  Nat Chem Biol       Date:  2013-12-01       Impact factor: 15.040

9.  Are 1,4- and 1,5-disubstituted 1,2,3-triazoles good pharmacophoric groups?

Authors:  Alberto Massarotti; Silvio Aprile; Valentina Mercalli; Erika Del Grosso; Giorgio Grosa; Giovanni Sorba; Gian Cesare Tron
Journal:  ChemMedChem       Date:  2014-07-30       Impact factor: 3.466

10.  Protein Conformational Changes Are Detected and Resolved Site Specifically by Second-Harmonic Generation.

Authors:  Ben Moree; Katelyn Connell; Richard B Mortensen; C Tony Liu; Stephen J Benkovic; Joshua Salafsky
Journal:  Biophys J       Date:  2015-08-18       Impact factor: 4.033

View more
  12 in total

1.  Design, synthesis, and biological evaluation of m-amidophenol derivatives as a new class of antitubercular agents.

Authors:  Niu-Niu Zhang; Zhi-Yong Liu; Jie Liang; Yun-Xiang Tang; Lu Qian; Ya-Min Gao; Tian-Yu Zhang; Ming Yan
Journal:  Medchemcomm       Date:  2018-06-07       Impact factor: 3.597

Review 2.  Structure-kinetic relationships that control the residence time of drug-target complexes: insights from molecular structure and dynamics.

Authors:  Hao Lu; James N Iuliano; Peter J Tonge
Journal:  Curr Opin Chem Biol       Date:  2018-07-06       Impact factor: 8.822

3.  Intracellular rebinding of transition-state analogues provides extended in vivo inhibition lifetimes on human purine nucleoside phosphorylase.

Authors:  Sara T Gebre; Scott A Cameron; Lei Li; Y S Babu; Vern L Schramm
Journal:  J Biol Chem       Date:  2017-08-09       Impact factor: 5.157

4.  Exploring the chemical space of 1,2,3-triazolyl triclosan analogs for discovery of new antileishmanial chemotherapeutic agents.

Authors:  Julia Fernández de Luco; Alejandro I Recio-Balsells; Diego G Ghiano; Ana Bortolotti; Juán Manuel Belardinelli; Nina Liu; Pascal Hoffmann; Christian Lherbet; Peter J Tonge; Babu Tekwani; Héctor R Morbidoni; Guillermo R Labadie
Journal:  RSC Med Chem       Date:  2020-11-05

5.  A Long Residence Time Enoyl-Reductase Inhibitor Explores an Extended Binding Region with Isoenzyme-Dependent Tautomer Adaptation and Differential Substrate-Binding Loop Closure.

Authors:  Sandra Eltschkner; Josef Kehrein; Thien Anh Le; Shabnam Davoodi; Benjamin Merget; Sneha Basak; Jonas D Weinrich; Johannes Schiebel; Peter J Tonge; Bernd Engels; Christoph Sotriffer; Caroline Kisker
Journal:  ACS Infect Dis       Date:  2021-03-12       Impact factor: 5.084

6.  A structure-kinetic relationship study using matched molecular pair analysis.

Authors:  Doris A Schuetz; Lars Richter; Riccardo Martini; Gerhard F Ecker
Journal:  RSC Med Chem       Date:  2020-09-21

7.  Drug-Target Kinetics in Drug Discovery.

Authors:  Peter J Tonge
Journal:  ACS Chem Neurosci       Date:  2017-07-14       Impact factor: 4.418

8.  Protein conformational flexibility modulates kinetics and thermodynamics of drug binding.

Authors:  M Amaral; D B Kokh; J Bomke; A Wegener; H P Buchstaller; H M Eggenweiler; P Matias; C Sirrenberg; R C Wade; M Frech
Journal:  Nat Commun       Date:  2017-12-22       Impact factor: 14.919

9.  Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.

Authors:  Katharigatta N Venugopala; Sandeep Chandrashekharappa; Pran Kishore Deb; Christophe Tratrat; Melendhran Pillay; Deepak Chopra; Nizar A Al-Shar'i; Wafa Hourani; Lina A Dahabiyeh; Pobitra Borah; Rahul D Nagdeve; Susanta K Nayak; Basavaraj Padmashali; Mohamed A Morsy; Bandar E Aldhubiab; Mahesh Attimarad; Anroop B Nair; Nagaraja Sreeharsha; Michelyne Haroun; Sheena Shashikanth; Viresh Mohanlall; Raghuprasad Mailavaram
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

10.  Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA.

Authors:  Yi Xia; Yasheen Zhou; David S Carter; Matthew B McNeil; Wai Choi; Jason Halladay; Pamela W Berry; Weimin Mao; Vincent Hernandez; Theresa O'Malley; Aaron Korkegian; Bjorn Sunde; Lindsay Flint; Lisa K Woolhiser; Michael S Scherman; Veronica Gruppo; Courtney Hastings; Gregory T Robertson; Thomas R Ioerger; Jim Sacchettini; Peter J Tonge; Anne J Lenaerts; Tanya Parish; Mrk Alley
Journal:  Life Sci Alliance       Date:  2018-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.